CRC cells are characterized by elevated expression of SMAD7, an intracellular protein, which interacts with the transforming growth factor (TGF)-β type I receptor, and suppresses TGF-β1-induced phosphorylation of Smad2/Smad3. This evidence concerns the gene SMAD7 and colorectal carcinoma.